First Manhattan CO Nex Immune, Inc. Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.3 - $0.6 $37,233 - $74,466	124,110 Added 496.44%	149,110 $56,000
Q4 2022 Feb 14, 2023	SELL	$0.21 - $18.5 $8,654 - $762,459	-41,214 Reduced 62.24%	25,000 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $15,000 - $437,500	-25,000 Reduced 27.41%	66,214 $36,000
Q1 2022 May 16, 2022	SELL	$1.79 - $4.65 $100,141 - $260,144	-55,945 Reduced 38.02%	91,214 $384,000
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $1.52 Million - $2.49 Million	147,159 New	147,159 $2.23 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $7.25M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.